Liquidia Corporation Common Stock vs Ross Stores, Inc. — how do they compare? Liquidia Corporation Common Stock trades at $33.9 (market cap $3.04B), while Ross Stores, Inc. trades at $233.68 (market cap $73.66B). The key difference: Ross Stores, Inc. is far larger — about 24.2× Liquidia Corporation Common Stock's market cap, and Ross Stores, Inc. pays a 0.77% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Ross Stores, Inc. for 48 Days on average.
| LQDA | ROST | |
|---|---|---|
Market Cap | $3.04B | $73.66B |
Volume | 21,111,778 | 1,784,732 |
Sector | Health | Consumer Cyclical |
52-Week High | $91.03 | $255.23 |
52-Week Low | $22.02 | $155.21 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $2.94B | $74.11B |
Dividend Yield | — | 0.77% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ross Stores (ROST) trades at $225.68, down slightly by 0.07% on the day, with a bearish technical signal despite strong fundamental performance. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $2.66 exceeding the $1.95 forecast. Revenue growth continues with 2025 reaching $21.13B, while maintaining robust profitability with a 10.85% net income margin and exceptional 42.63% return on equity.
Wall Street maintains a bullish outlook with 64% buy ratings and a $274.14 consensus price target representing 21% upside potential. Key risks include competitive pressures in discount retail and potential margin compression from expansion costs. The stock's current technical weakness presents a potential entry point for investors confident in the company's store expansion strategy and value-focused merchandising approach.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →